Fmr LLC Biocryst Pharmaceuticals Inc Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Fmr LLC holds 655,893 shares of BCRX stock, worth $4.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

655,893

Previous 583,614 12.38%

Holding current value

$4.41 Million

Previous $4.38 Million 34.25%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$6.41 - $11.19 $463,308 - $808,802	72,279 Added 12.38%	655,893 $5.88 Million
Q1 2025 May 12, 2025	SELL	$7.06 - $9.39 $1.37 Million - $1.82 Million	-193,654 Reduced 24.91%	583,614 $4.38 Million
Q4 2024 Feb 13, 2025	SELL	$7.03 - $8.43 $8.51 Million - $10.2 Million	-1,211,121 Reduced 60.91%	777,268 $5.85 Million
Q3 2024 Nov 13, 2024	BUY	$6.41 - $8.69 $295,565 - $400,695	46,110 Added 2.37%	1,988,389 $15.1 Million
Q2 2024 Aug 13, 2024	BUY	$4.13 - $6.79 $442,748 - $727,908	107,203 Added 5.84%	1,942,279 $12 Million
Q1 2024 May 13, 2024	SELL	$4.89 - $7.65 $4.31 Million - $6.74 Million	-880,818 Reduced 32.43%	1,835,076 $9.32 Million
Q4 2023 Feb 13, 2024	SELL	$4.98 - $6.77 $1.18 Million - $1.61 Million	-237,479 Reduced 8.04%	2,715,894 $16.3 Million
Q3 2023 Nov 13, 2023	BUY	$6.71 - $7.92 $23,988 - $28,314	3,575 Added 0.12%	2,953,373 $20.9 Million
Q2 2023 Aug 11, 2023	SELL	$6.96 - $8.81 $1.52 Million - $1.92 Million	-217,712 Reduced 6.87%	2,949,798 $20.8 Million
Q1 2023 May 11, 2023	SELL	$7.94 - $11.84 $31.4 Million - $46.8 Million	-3,953,485 Reduced 55.52%	3,167,510 $26.4 Million
Q4 2022 Feb 13, 2023	BUY	$10.5 - $14.2 $14.8 Million - $20.1 Million	1,413,928 Added 24.78%	7,120,995 $81.7 Million
Q3 2022 Nov 10, 2022	BUY	$10.79 - $14.81 $5.6 Million - $7.69 Million	519,290 Added 10.01%	5,707,067 $71.9 Million
Q2 2022 Aug 12, 2022	SELL	$7.89 - $17.88 $25.5 Million - $57.7 Million	-3,226,681 Reduced 38.35%	5,187,777 $54.9 Million
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $52.2 Million - $89.3 Million	4,518,210 Added 115.96%	8,414,458 $137 Million
Q4 2021 Feb 14, 2022	BUY	$11.18 - $15.46 $31 Million - $42.9 Million	2,772,069 Added 246.59%	3,896,248 $54 Million
Q3 2021 Nov 15, 2021	SELL	$14.21 - $17.65 $2,188 - $2,718	-154 Reduced 0.01%	1,124,179 $16.2 Million
Q2 2021 Aug 13, 2021	BUY	$9.5 - $17.24 $10.7 Million - $19.4 Million	1,124,333 New	1,124,333 $17.8 Million

Others Institutions Holding BCRX

# of Institutions

315

Shares Held

201M

Call Options Held

930K

Put Options Held

553K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.25B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account